Next |
home / stock / mrkr / mrkr message board
Subject | By | Source | When |
---|---|---|---|
https://finance.yahoo.com/news/marker-therapeutics-reports-mt-401-110000404.html | abracky | investorshub | 06/26/2023 4:10:50 PM |
https://www.globenewswire.com/en/news-release/2023/06/26/2694294/0/en/Marker-The | jobynimble | investorshub | 06/26/2023 1:19:31 PM |
My pleasure | jobynimble | investorshub | 06/26/2023 1:13:54 PM |
So my obvious question would be: with all | microcapbiotech | investorshub | 06/26/2023 1:10:23 PM |
non-clinical data on its lead multi-tumor-associated antigen (multiTAA)-specific | microcapbiotech | investorshub | 06/26/2023 1:04:16 PM |
Once Again, As Always, THANK YOU | microcapbiotech | investorshub | 06/26/2023 12:56:02 PM |
News out | jobynimble | investorshub | 06/26/2023 12:48:17 PM |
Phanton, any opinions on my previous post # | microcapbiotech | investorshub | 06/25/2023 10:54:13 PM |
Short selling and Naked short selling info. Thank | microcapbiotech | investorshub | 06/25/2023 10:51:07 PM |
The bs has to be called out for | jobynimble | investorshub | 06/25/2023 10:26:29 PM |
If we all ignore him he's bound to | Phantom Lord | investorshub | 06/25/2023 9:43:16 PM |
Short selling a fundamentally strong company doesnt matter | jobynimble | investorshub | 06/25/2023 6:50:19 PM |
I believe, but am not positive that at | microcapbiotech | investorshub | 06/25/2023 5:55:47 PM |
Show me an article from a reputable source, | jobynimble | investorshub | 06/25/2023 2:34:37 PM |
Always amazes me the most basic investment comments | learningcurve2020 | investorshub | 06/25/2023 1:36:46 PM |
trying to point out the obvious or use | microcapbiotech | investorshub | 06/24/2023 6:57:12 PM |
OTCBBs easier to short than NASDAQ? LOL! Where | jobynimble | investorshub | 06/24/2023 5:24:04 PM |
The difference is that I only dream for | microcapbiotech | investorshub | 06/24/2023 4:33:50 PM |
Talk about rambling! LOL First off, this is wrong. | learningcurve2020 | investorshub | 06/24/2023 2:43:33 PM |
Nice action today! | GMA13 | investorshub | 06/23/2023 8:43:21 PM |
News, Short Squeeze, Breakout and More Instantly...
Marker Therapeutics Inc. Company Name:
MRKR Stock Symbol:
NASDAQ Market:
Marker Therapeutics Inc. Website:
Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study Study participant with Non-Hodgkin’s Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell therapy remains in complete response...
Preliminary data from study in patients with lymphoma enrolled at City of Hope National Medical Center was presented at the 11th Global Summit on ...
Preliminary data from study in patients with lymphoma enrolled at City of Hope National Medical Center was presented at the 11 th Global Summit on Hematologic Malignancies in Whistler, BC, Canada Study participants tolerated initial dose level well and demonstrated durab...